Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


24.06.2019

1 AJNR Am J Neuroradiol
1 Ann Neurol
1 BMC Neurol
1 Brain
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
1 Lancet Neurol
6 Mult Scler
1 PLoS One
2 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. MARANZANO J, Dadar M, Rudko DA, De Nigris D, et al
    Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
    AJNR Am J Neuroradiol. 2019 Jun 20. pii: ajnr.A6099. doi: 10.3174/ajnr.A6099.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. MUNGER KL, Hongell K, Cortese M, Aivo J, et al
    Epstein-Barr virus and multiple sclerosis risk in the Finnish Maternity Cohort.
    Ann Neurol. 2019 Jun 21. doi: 10.1002/ana.25532.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. KOLB-MAURER A, Sunderkotter C, Kukowski B, Meuth SG, et al
    An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.
    BMC Neurol. 2019;19:130.
    PubMed     Text format     Abstract available


    Brain

  4. FILIPPI M, Preziosa P, Banwell BL, Barkhof F, et al
    Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
    Brain. 2019 Jun 17. pii: 5519813. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurol

  5. BAJRAMI A, Pitteri M, Castellaro M, Pizzini F, et al
    The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.
    J Neurol. 2018 Jun 25. pii: 10.1007/s00415-018-8952.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  6. SIMPSON S JR, Wang W, Otahal P, Blizzard L, et al
    Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.
    J Neurol Neurosurg Psychiatry. 2019 Jun 19. pii: jnnp-2018-320189.
    PubMed     Text format     Abstract available


    J Neurol Sci

  7. ZURAWSKI J, Glanz BI, Healy BC, Tauhid S, et al
    The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.
    J Neurol Sci. 2019;403:38-43.
    PubMed     Text format     Abstract available


    Lancet Neurol

  8. FEINSTEIN A
    Wordsworth, Bellow, and understanding multiple sclerosis.
    Lancet Neurol. 2019 Jun 14. pii: S1474-4422(19)30222.
    PubMed     Text format    


    Mult Scler

  9. CHARD DT
    Commentary on Al Hussona et al. 'New-onset seizures as a sole clinical presentation of multiple sclerosis'.
    Mult Scler. 2019;25:298-299.
    PubMed     Text format     Abstract available

  10. CAMBRON M, Mostert J, D'Hooghe M, Nagels G, et al
    Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
    Mult Scler. 2019 Jun 20:1352458519843051. doi: 10.1177/1352458519843051.
    PubMed     Text format     Abstract available

  11. CHATAWAY J, Weir CJ, Fox RJ
    The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials.
    Mult Scler. 2019 Jun 20:1352458519856985. doi: 10.1177/1352458519856985.
    PubMed     Text format    

  12. FUCHS TA, Benedict RH, Wilding G, Wojcik C, et al
    Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis.
    Mult Scler. 2019 Jun 20:1352458519858605. doi: 10.1177/1352458519858605.
    PubMed     Text format     Abstract available

  13. MARCK CH, das Nair R, Grech LB, Borland R, et al
    Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success.
    Mult Scler. 2019 Jun 20:1352458519858730. doi: 10.1177/1352458519858730.
    PubMed     Text format     Abstract available

  14. PERONI S, Sorosina M, Malhotra S, Clarelli F, et al
    A pharmacogenetic study implicates NINJ2 in the response to Interferon-beta in multiple sclerosis.
    Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428.
    PubMed     Text format     Abstract available


    PLoS One

  15. FELLOWS MAXWELL K, Wahls T, Browne RW, Rubenstein L, et al
    Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
    PLoS One. 2019;14:e0218075.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. KREMER D, Gruchot J, Weyers V, Oldemeier L, et al
    pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2019 Jun 18. pii: 1901283116.
    PubMed     Text format     Abstract available


  17. Correction for McKenzie et al., Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2019 Jun 17. pii: 1909025116.
    PubMed     Text format    


    Rev Neurol (Paris)

  18. JOLY H, Cohen M, Bresch S, Lebrun-Frenay C, et al
    Impact of executive dysfunction on naming ability in multiple sclerosis.
    Rev Neurol (Paris). 2019 Jun 17. pii: S0035-3787(18)30726.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: